What it sells
Flow Medical is developing the HELYX-PE catheter system for treating pulmonary embolism; the system is not yet commercially available.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-11-03 | — | $6M | — | news.google.com |
| 2026-11-01 | — | $6M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-11-10.